|
|
Office Locations:
|
500 Union Street, Suite 835
Seattle, WA 98101
Phone: 206-682-1181
Fax: 206-682-8077
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Pacific Horizon Ventures is a Seattle-based, early-stage venture capital firm concentrating on commercial development of novel technologies for biopharmaceutical and biomedical products. PHV prefers validation-phase investments to be in the Northwest so that the firm can devote substantial time and energy to the company's development. Other early and mid-stage investments can be in companies across North America. The firm maintains an active interest in biotechnology, drug development, therapeutic and diagnostic medical devices, computational biology and selected healthcare.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
